Benitec Biopharma DPO Ratio 2011-2026 | BNTC

Annual DPO Ratio Benitec Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-556	1.26 K	469	233	1.41 K	6.94 K	6.94 K	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
6.94 K	-556	2.38 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Amgen AMGN	64.8	$ 350.17	0.68 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	31.7	$ 19.57	0.36 %	$ 915 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Aytu BioScience AYTU	186	$ 2.64	1.15 %	$ 16.6 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	507	$ 1.58	3.62 %	$ 185 M	USA
Cellectis S.A. CLLS	975	$ 3.35	0.3 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
CorMedix CRMD	79.3	$ 6.29	0.64 %	$ 453 K	USA
Clovis Oncology CLVS	236	-	-7.23 %	$ 13 M	USA
Compugen Ltd. CGEN	82.7	$ 2.12	1.2 %	$ 198 M	Israel
Dyadic International DYAI	179	$ 0.89	-5.85 %	$ 25.6 M	USA
Arbutus Biopharma Corporation ABUS	23	$ 4.26	0.47 %	$ 707 M	Canada